Brief: Rhythm Biosciences Receives Tranche Of A$1M In Non-Dilutive Funding From Endpoints Capital
30/06/2025 09:19
June 30 (Reuters) - Rhythm Biosciences Ltd RHY.AX: RECEIVED TRANCHE OF A$1M IN NON-DILUTIVE FUNDING FROM ENDPOINTS CAPITAL Further company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt